Biosimilar Innovation
Friday, February 8, 2019
8:30 a.m.–5:00 p.m.
UC Irvine School of Law, MPAA 420 (Directions)
Biosimilar medical products offer the promise of enhanced medical therapies at sustainable pricing. However, the scientific and economic challenges associated with biosimilars threaten to impede the promise of such medical advances. New incentive strategies are needed to advance development in this area.
To address such challenges, speakers at this conference will explore the legal and regulatory frameworks needed to encourage innovative development and distribution of biosimilar products.
Confirmed participants include:
- Dan L. Burk (UC Irvine)
- Michael Carrier (Rutgers University, Camden)
- Timo Minssen (University of Copenhagen)
- Jordan Paradise (Loyola University, Chicago)
- Nicholson Price (University of Michigan)
- Jacob Sherkow (NY Law School)
- Brenda Simon (Thomas Jefferson)
- Ariel Stern (Harvard Business School)
This event is approved for 5.5 hours of Continuing Legal Education Credit by the State Bar of California. UC Irvine School of Law is a State Bar-approved MCLE provider.
For more event details or to request reasonable accommodations for a disability, please email events@law.uci.edu